Date | Price Target | Rating | Analyst |
---|---|---|---|
8/18/2023 | $15.00 | Buy | BTIG Research |
4/21/2023 | $11.00 | Overweight | Cantor Fitzgerald |
4/19/2022 | $11.00 | Buy | Deutsche Bank |
1/19/2022 | $14.00 | Buy | Stifel |
12/21/2021 | $13.00 | Buy | Canaccord Genuity |
12/7/2021 | $14.00 | Buy | Needham |
11/30/2021 | $16.00 → $22.00 | Outperform | Northland Capital Markets |
11/30/2021 | $14.00 | Overweight | Barclays |
DocGo Inc. (NASDAQ:DCGO) ("DocGo"), a leading provider of technology-enabled mobile health services, announced today that management will be participating in the following investor conferences in August and September: Midwest Ideas Conference (August 28th – 29th) Norm Rosenberg, Chief Financial Officer will participate in 1x1 meetings, and deliver a presentation on Wednesday August 28th at 3:45PM. A webcast of the event will be available on the investor relations section of DocGo's website at https://ir.docgo.com/. Morgan Stanley 22nd Annual Global Healthcare Conference (September 4th – 6th) Lee Bienstock, Chief Executive Officer will hold 1x1 meetings, and participate in a fireside cha
Company Raises Cash Flow From Operations Guidance to $80-$90 Million, Reiterates 2024 Revenue Guidance of $600-$650 Million and Adjusted EBITDA1 Guidance of $65-$75 Million Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time (Note Corrected Call Information Below) DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced financial and operating results for the quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights Total revenue for the second quarter of 2024 was $164.9 million, compared to $125.5 million in the second quarter of 2023, an increase of 31%. GAAP gros
Innovative Collaboration Leverages Mobile Health Services and Advanced Artificial Intelligence Technology To Bring Care Directly to Vulnerable Populations DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced the launch of an innovative mobile x-ray program in partnership with MinXray. The program launched in New York City to provide rapid and accessible chest x-rays for vulnerable populations and help identify active Tuberculosis ("TB") cases. With increasing TB cases in cities across the US, this program is a timely response to a growing public health challenge. DocGo's mobile units, equipped with MinXray'
DocGo stood out as one of the top companies to meet employee needs. DocGo (NASDAQ:DCGO), a leading provider of technology-enabled mobile health services is pleased to announce that U.S. News & World Report, the global authority in rankings and consumer advice, has named DocGo one of the 2024-2025 Best Companies to Work For. DocGo was rated among the Best Companies to Work For ‑ Northeast on factors contributing to job seekers' decision-making when choosing a workplace that best meets their needs. "A key aspect of DocGo's success is our incredible team of passionate, dedicated professionals, and we're always looking for the best of the best to join us," said Lee Bienstock, CEO of DocGo
DocGo hires Jen McLean and Yong Kim as Vice Presidents DocGo Inc. (NASDAQ:DCGO), a leading provider of technology-enabled mobile health services, today announced the addition of two senior leaders bringing significant experience in large-scale public health program management and value-based care partnerships with health plans. Yong Kim has joined as Vice President of Health Plan Partnerships from his most recent role leading business operations and strategy for CVS Health's population health and care management programs. Jen McLean has joined as Vice President of Government and Public Health Programs from her most recent role as Chief Operating Officer of City Harvest in New York City.
DocGo Inc. (NASDAQ:DCGO) ("DocGo"), a leading provider of technology-enabled mobile health services, today announced that its medical staffing division that services federal agencies achieved the coveted ISO 9001:2015 certification. This Quality Management Systems ("QMS") standard sets the bar for quality assurance, emphasizing continuous improvement, customer satisfaction, and efficient processes. This certification represents a significant milestone, demonstrating the company's commitment to the highest standards of quality management. "Achieving ISO certification is an important step in our growth trajectory," said Tim Harvey, General Manager at DocGo. "Our team works with the most val
Company Raises Cash Flow From Operations Guidance to $80-$90 Million, Reiterates 2024 Revenue Guidance of $600-$650 Million and Adjusted EBITDA1 Guidance of $65-$75 Million Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time (Note Corrected Call Information Below) DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced financial and operating results for the quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights Total revenue for the second quarter of 2024 was $164.9 million, compared to $125.5 million in the second quarter of 2023, an increase of 31%. GAAP gros
Management to host conference call and webcast at 5:00 p.m. ET on that day DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the second quarter ended June 30, 2024 after the markets close on Wednesday, August 7, 2024. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Wednesday, August 7, 2024 5:00 p.m. ET 1-877-343-4136 (U.S.) 1-203-518-9843 (international) Conference ID: DOCGO A webcast of the conference call can be accessed under Events on the Investors sectio
Company Reports First Quarter Net Income of $10.6 Million and Record Adjusted EBITDA1 of $24.1 Million Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced financial and operating results for the quarter ended March 31, 2024. First Quarter 2024 Financial Highlights Total revenue for the first quarter of 2024 was $192.1 million, compared to $113.0 million in the first quarter of 2023, an increase of 70%. Gross margin for the first quarter of 2024 was 35.0%, compared to the gross margin in the first quarter of 2023 of 28.1%.
10-Q - DocGo Inc. (0001822359) (Filer)
8-K - DocGo Inc. (0001822359) (Filer)
8-K - DocGo Inc. (0001822359) (Filer)
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
BTIG Research initiated coverage of DocGo with a rating of Buy and set a new price target of $15.00
Cantor Fitzgerald initiated coverage of DocGo with a rating of Overweight and set a new price target of $11.00
Deutsche Bank initiated coverage of DocGo with a rating of Buy and set a new price target of $11.00
SC 13G/A - DocGo Inc. (0001822359) (Subject)
SC 13G/A - DocGo Inc. (0001822359) (Subject)
SC 13G/A - DocGo Inc. (0001822359) (Subject)
DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"),a leading provider of technology-enabled mobile health services, today announced it has secured five new contracts that include remote patient monitoring (RPM), virtual care management (VCM), chronic care management (CCM), cardiac implantable electronic device (CIED), and a care gap closure program for a national health plan. These noteworthy examples of new DocGo contracts expand the Company's reach and ability to deliver quality virtual, in-person, and mobile healthcare services.
BTIG analyst David Larsen maintains DocGo (NASDAQ:DCGO) with a Buy and lowers the price target from $11 to $7.